Stock BEVIDES B FARMACIAS BENAVIDES, S.A.B. DE C.V.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Farmacias Benavides, S.A.B. de C.V.

Equities

BEVIDES B

MXP3895X1106

Drug Retailers

End-of-day quote Mexican S.E.
Other stock markets
 06:00:00 2024-04-07 pm EDT 		5-day change 1st Jan Change
18.9 MXN -0.53% Intraday chart for Farmacias Benavides, S.A.B. de C.V. -.--% -0.53%
2023 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 6,950 6,950 7,159 6,950 3,712 3,688
Enterprise Value (EV) 1 8,046 8,917 11,673 10,877 6,382 6,248
P/E ratio -10.2 x -22.8 x -52.4 x -25 x 382 x 29 x
Yield - - - - - -
Capitalization / Revenue 0.51 x 0.5 x 0.51 x 0.5 x 0.25 x 0.23 x
EV / Revenue 0.6 x 0.65 x 0.84 x 0.78 x 0.43 x 0.39 x
EV / EBITDA -23.3 x 146 x 25.4 x 33.1 x 9.35 x 6.49 x
EV / FCF -22.3 x -10.4 x 29 x 13.8 x 4.51 x 5.22 x
FCF Yield -4.49% -9.62% 3.44% 7.27% 22.2% 19.2%
Price to Book 9.58 x 15.8 x 25.6 x -176 x -90.9 x 20.3 x
Nbr of stocks (in thousands) 408,844 408,844 408,844 408,844 408,844 408,844
Reference price 2 17.00 17.00 17.51 17.00 9.080 9.020
Announcement Date 5/29/18 6/2/19 4/30/20 5/3/21 5/11/22 5/2/23
1MXN in Million2MXN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 13,498 13,814 13,911 13,869 14,743 16,218
EBITDA 1 -345.2 61.23 459.6 328.1 682.3 963.3
EBIT 1 -520.2 -183.7 188.4 124.4 525.7 712.6
Operating Margin -3.85% -1.33% 1.35% 0.9% 3.57% 4.39%
Earnings before Tax (EBT) 1 -601.4 -348.5 -129.1 -282.5 235.3 349.5
Net income 1 -683.6 -305.2 -136.7 -278.2 9.711 127.3
Net margin -5.06% -2.21% -0.98% -2.01% 0.07% 0.78%
EPS 2 -1.672 -0.7466 -0.3344 -0.6804 0.0238 0.3114
Free Cash Flow 1 -361.1 -857.4 402 790.9 1,415 1,197
FCF margin -2.68% -6.21% 2.89% 5.7% 9.6% 7.38%
FCF Conversion (EBITDA) - - 87.47% 241.03% 207.34% 124.26%
FCF Conversion (Net income) - - - - 14,567.79% 940.3%
Dividend per Share - - - - - -
Announcement Date 5/29/18 6/2/19 4/30/20 5/3/21 5/11/22 5/2/23
1MXN in Million2MXN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 1,096 1,966 4,515 3,926 2,669 2,560
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -3.175 x 32.11 x 9.823 x 11.97 x 3.912 x 2.657 x
Free Cash Flow 1 -361 -857 402 791 1,415 1,197
ROE (net income / shareholders' equity) -64% -52.3% -37.9% -232% -24.2% 127%
ROA (Net income/ Total Assets) -5.68% -1.89% 1.56% 0.94% 4.46% 6.07%
Assets 1 12,043 16,159 -8,750 -29,544 217.6 2,096
Book Value Per Share 2 1.770 1.080 0.6800 -0.1000 -0.1000 0.4400
Cash Flow per Share 2 0.8800 0.9600 1.200 0.9900 1.210 1.550
Capex 1 346 446 252 222 192 348
Capex / Sales 2.56% 3.23% 1.81% 1.6% 1.3% 2.15%
Announcement Date 5/29/18 6/2/19 4/30/20 5/3/21 5/11/22 5/2/23
1MXN in Million2MXN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Retail - Drugs with Grocery

1st Jan change Capi.
FARMACIAS BENAVIDES, S.A.B. DE C.V. Stock Farmacias Benavides, S.A.B. de C.V.
-0.53% 454M
COSMOS PHARMACEUTICAL CORPORATION Stock COSMOS Pharmaceutical Corporation
-9.73% 3.81B
SUNDRUG CO.,LTD. Stock Sundrug Co.,Ltd.
-0.73% 3.44B
TSURUHA HOLDINGS INC. Stock Tsuruha Holdings Inc.
-23.44% 3.15B
LBX PHARMACY CHAIN Stock LBX Pharmacy Chain
+11.98% 2.71B
KUSURI NO AOKI HOLDINGS CO., LTD. Stock Kusuri No Aoki Holdings Co., Ltd.
-9.90% 1.79B
CREATE SD HOLDINGS CO., LTD. Stock Create SD Holdings Co., Ltd.
+11.26% 1.43B
GREAT TREE PHARMACY CO., LTD. Stock Great Tree Pharmacy Co., Ltd.
-20.03% 974M
SHUYU CIVILIAN PHARMACY CORP., LTD. Stock ShuYu Civilian Pharmacy Corp., Ltd.
-37.98% 710M
CAWACHI LIMITED Stock Cawachi Limited
+5.58% 409M
Retail - Drugs with Grocery
  1. Stock Market
  2. Equities
  3. BEVIDES B Stock
  4. Financials Farmacias Benavides, S.A.B. de C.V.